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Background and PurposezzHyperkalemic periodic paralysis (hyperKPP) is a muscle sodi-
um-ion channelopathy characterized by recurrent paralytic attacks. A proportion of affected 
individuals develop fixed or chronic progressive weakness that results in significant disability. 
However, little is known about the pathology of hyperKPP-induced fixed weakness, includ-
ing the pattern of muscle involvement. The aim of this study was to characterize the patterns 
of muscle involvement in hyperKPP by whole-body magnetic resonance imaging (MRI).
MethodszzWe performed whole-body muscle MRI in seven hyperKPP patients carrying the 
T704M mutation in the SCN4A skeletal sodium-channel gene. Muscle fat infiltration, sugges-
tive of chronic progressive myopathy, was analyzed qualitatively using a grading system and 
was quantified by the two-point Dixon technique.
ResultszzWhole-body muscle MRI analysis revealed muscle atrophy and fatty infiltration in 
hyperKPP patients, especially in older individuals. Muscle involvement followed a selective 
pattern, primarily affecting the posterior compartment of the lower leg and anterior thigh 
muscles. The muscle fat fraction increased with patient age in the anterior thigh (r=0.669, 
p=0.009), in the deep posterior compartment of the lower leg (r=0.617, p=0.019), and in the 
superficial posterior compartment of the lower leg (r=0.777, p=0.001).
ConclusionszzOur whole-body muscle MRI findings provide evidence for chronic progres-
sive myopathy in hyperKPP patients. The reported data suggest that a selective pattern of 
muscle involvement—affecting the posterior compartment of the lower leg and the anterior 
thigh—is characteristic of chronic progressive myopathy in hyperKPP.
Key Wordszz hyperkalemic periodic paralysis, chronic progressive myopathy, muscle MRI, 
fat quantification, two-point Dixon technique.
Whole-Body Muscle MRI in Patients with Hyperkalemic  
Periodic Paralysis Carrying the SCN4A Mutation T704M: 
Evidence for Chronic Progressive Myopathy with Selective 
Muscle Involvement 
INTRODUCTION
Hyperkalemic periodic paralysis (hyperKPP) is an autosomal-dominant muscle sodium-ion 
channelopathy with a high degree of penetrance. It is caused by mutations in the SCN4A 
gene, which encodes the α subunit of the skeletal muscle voltage-gated sodium-channel 
Nav1.4.1,2 HyperKPP is characterized by attacks of generalized or focal flaccid muscle weak-
ness. Although most affected individuals have normal muscle strength between attacks, 
some develop fixed or chronic progressive weakness, independently of the presence of epi-
sodic attacks.3-5 Fixed weakness in hyperKPP appears to be common in older patients with 
a long disease duration.3,4 It has been proposed that Na+ overload in muscle fibers can lead 
to muscle degeneration that increases with age.6 However, little is known about the devel-
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opment of fixed weakness in hyperKPP, including the pattern 
of muscle involvement.
Muscle magnetic resonance imaging (MRI) is a very useful 
method for evaluating muscle involvement, visualizing mus-
cle fat content, and quantifying the fat fraction in muscle dis-
orders.7 Characterization of the muscle involvement patterns 
in several muscle disorders has improved the diagnostic work-
up process and guided genetic testing. MRI of muscle can 
also reveal the replacement of skeletal muscle by fat, which 
occurs in the late stages of many muscle disorders.8 A previ-
ous muscle MRI study found that hyperKPP patients with 
fixed weakness showed more fatty change in calf muscles 
compared to those without fixed weakness and healthy con-
trols.6 However, that study could not elucidate the whole-
body muscle involvement patterns since only the lower leg 
was evaluated. In addition, fat-fraction maps of patients with 
hyperKPP have not been reported previously, particularly 
such maps obtained by Dixon-based fat and water mapping 
technique. Thus, the aim of the present study was to charac-
terize the patterns of muscle involvement in hyperKPP pa-
tients with the SCN4A mutation T704M with the aid of 
whole-body MRI.
METHODS
Patients
This study was approved by the Institutional Review Board at 
our institution (IRB no. 4-2013-0167). Written informed con-
sent was obtained from all patients. Seven hyperKPP patients 
from one family were included in this study. Genetic analysis 
was performed, and all seven patients were found to have the 
T704M mutation in the SCN4A gene (Fig. 1). The clinical fea-
tures of the patients are summarized in Table 1.
Manual muscle strength
Manual muscle strength was measured according to the modi-
fied Medical Research Council scale converted to a score from 
0 to 10 points as follows to facilitate the purposes of our anal-
ysis: 0=0, 1=1, 2=2, 3-=3, 3=4, 3+=5, 4W=6, 4=7, 4S=8, 5-=9, 
and 5=10.9 Two neurologists (H.E.L. and H.S.L. with 2 years 
and 1 year of experience in neuromuscular disorders, respec-
tively) who were blinded to the clinical information assessed 
the scale using consensus. Muscle strength was evaluated dur-
ing the interictal state on the same day as the MRI scan.
Fig. 1. Pedigree of a family with hyperkalemic periodic paralysis and mutation of the SCN4A gene. A: Family pedigree with affected individuals 
shown as solid symbols. B: Genomic DNA sequence electropherogram of patient II:1 showing a heterozygous p.T704M SCN4A mutation arrow, 
which is present in all patients, but not in healthy family members.
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Table 1. Clinical features of patients with hyperkalemic periodic paralysis due to the SCN4A mutation T704M
Patient  
ID
Sex
Age  
(years)
Onset 
period
Weakness  
between attacks*
Paramyotonia
Myotonic  
discharges on EMG
Response to  
acetazolamide
CK  
(IU/L)
II:1 M 49 Infant + + + – 584
II:2 M 47 Infant + + + – 292
II:3 M 45 Infant + + + – 875
III:1 M 21 Infant + + + – 430
III:2 M 21 Infant + + + – 1,626
III:3 M 19 Infant + + + – 618
III:4 F 14 Infant – + + – 502
*Weakness between attacks was self-reported by patients.
CK: creatine kinase (reference value: 44–245 IU/L), EMG: electromyography, F: female, M: male, SCN4A: gene encoding the α subunit of the skeletal 
muscle sodium-channel Nav1.4.
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Muscle imaging
In all seven patients, whole-body MRI was performed using a 
3.0-T MRI system (Magnetom Trio, Siemens, Erlangen, Ger-
many), which was equipped with multiple phased-array sur-
face coils with a maximum gradient amplitude of 40 mT/m 
and a maximum slew rate of 200 mT/m/ms. A series of imag-
es acquired successively in a coronal orientation at an identi-
cal slice level was automatically combined to generate a single 
coronal composite view using the manufacturer’s optional 
software. No manual realignment was needed.
The following parameters were typically used using data 
acquisition:
1) Axial in-phase and opposed-phase T1-weighted volumet-
ric interpolated brain examination (VIBE), with relaxation 
time (TR)=10 ms, echo time 1 (TE1)/echo time 2 (TE2)= 
2.45/3.68 ms, and field of view (FOV)=24 cm for the forearm, 
and TR=5.54 ms, TE1/TE2=2.45/3.68 ms, and FOV=50 cm 
for the thigh and lower leg. Other parameters included slice 
thickness=5 mm, number of slices=60, acquisition matrix= 
256×192, flip angle (FA)=13°, and number of excitations 
(NEX)=1. 
2) T1-weighted fast spin echo (FSE) MR images, with TR/
TE=550/12 ms and FOV=20 cm for the forearm, TR/TE= 
557/11 ms, and FOV=50 cm for the thigh, and TR/TE=608/ 
11 ms and FOV=50 cm for the lower leg. Other parameters 
included slice thickness=5 mm, interslice space=10 mm, ac-
quisition matrix=384×308, FA=14°, and NEX=2.
No paramagnetic contrast agent was injected, and neither 
cardiac nor respiratory gating was performed. A multi-breath-
hold option was added to the thoracic sequence steps in spon-
taneously breathing patients who were able to hold their breath.
After the MRI scan, water and fat maps were reformatted 
from in-phase (TE1=2.45 ms) and opposed-phase (TE2=3.68 
ms) MR images in the console. The fat-fraction map was ob-
tained using the equation [F/(W+F)]×100, where F and W are 
the signal intensities of the fat and water maps, respectively. 
Data analysis
All images were assessed using consensus by two musculoskel-
etal radiologists with expertise in MRI and who were blinded 
to the clinical information (Y.H.L. and S.H. with 9 years and 1 
year of experience in musculoskeletal MRI, respectively). 
Analyses of axial in-phase and opposed-phase T1-weighted 
VIBE MR images of the forearm, thigh, and lower leg were 
performed by a commercial Picture Archiving and Commu-
nication System (PACS) viewer (Centricity® PACS RA1000, 
GE Healthcare, Barrington, IL, USA). The exact locations of 
axial images were determined using the coronal images as a 
reference. 
Muscles were assessed for both atrophy and fatty infiltra-
tion. Muscle atrophy was defined as an obvious loss of mus-
cle volume, and scored as present or absent. The fatty infiltra-
tion as evident in T1-weighted FSE images was assessed 
according to the distribution of abnormal muscle signal in-
tensities, and the grade of involvement was ranked from 1 to 
4 as described previously:10 1, normal appearance; 2, mild in-
volvement of less than 30% of the muscle; 3, moderate in-
volvement of 30% to 60%; and 4, severe involvement of more 
than 60%. The following muscles were assessed: infraspina-
tus, supraspinatus, subscapularis, biceps brachii, triceps, flex-
or carpi ulnaris, flexor carpi radialis, flexor digitorum profun-
dus, flexor digitorum superficialis, brachioradialis, extensor 
carpi ulnaris, extensor carpi radialis, extensor digitorum com-
munis, supinator, pronator teres, gluteus minimus, gluteus me-
dius, gluteus maximus, iliopsoas, obturatorius internus, obturato-
rius externus, pectineus, rectus femoris, vastus lateralis, vastus 
medialis, vastus intermedius, semimembranosus, semitendino-
sus, biceps femoris, sartorius, gracilis, adductor brevis, adductor 
longus, adductor magnus, gastrocnemius lateralis, gastrocne-
mius medialis, soleus, tibialis anterior, tibialis posterior, extensor 
digitorum longus, and peroneus. In total, 84 muscles were eval-
uated.
Fatty infiltration was quantified by assessing the fat fraction 
from fat and water maps derived from the in-phase and op-
posed-phase VIBE MR images by using region-of-interest 
(ROI) analysis. The fat fraction was quantified by performing 
measurements in 5×5 mm2 ROIs. When heterogeneously fatty 
changes in muscles were observed in in-phase VIBE MR im-
ages, the ROIs were positioned in the area with the greatest 
fatty change per unit area of muscle. Measurement-related er-
rors and intraobserver variability were minimized by measur-
ing the ROIs twice, with the average values being recorded. 
The dorsal and ventral muscle groups of the forearm were re-
corded at the middle level of the forearm; the anterior, medial, 
and posterior muscle groups of the thigh were recorded at the 
lower-third level of the thigh; and the anterior, lateral, deep 
posterior, and superficial posterior muscle groups of the lower 
leg were recorded at the middle-to-lower level of the lower leg.
Genetic analysis
Genomic DNA was extracted from peripheral blood lym-
phocytes of patients using a standard protocol, and the en-
tire 24 coding exons and the exon-intron boundaries in the 
SCN4A gene were amplified by the polymerase chain reac-
tion (PCR). The primer sequences and PCR amplification 
conditions are available upon request. The PCR products 
were electrophoresed on 1.2% agarose gels, and the amplified 
genomic DNA fragments were extracted and purified using 
the QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s recommended protocol. Both 
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strands were directly sequenced with BigDye terminator 
chemistry (PE-Applied Biosystems, Foster City, CA, USA), 
and each electropherogram was analyzed using Chromas 
2.33 software (Technelysium, Queensland, Australia).
Statistical analysis
The Mann-Whitney U test and Fisher’s exact test were used 
to compare continuous and categorical variables, respective-
ly. The relationships of the muscle fat fraction with patient 
age and manual muscle strength were assessed by Pearson 
correlation coefficients. Statistical analyses were performed 
using IBM SPSS statistics software (SPSS Windows version 
20.0, IBM, Armonk, NY, USA). A two-tailed probability val-
ue of p<0.05 was considered statistically significant.
RESULTS
Manual muscle strength
Manual muscle strength was measured on the same day that 
the MRI scan was performed; the results are presented in Sup-
plementary Table 1 (in the online-only Data Supplement). The 
manual muscle strength score was 8, 9, or 10 in most muscles 
across the study patients, and lowest in patient II:1. The muscle 
strength of patient III:4 was normal in all muscle groups.
MRI findings
MRI scans were performed on all study participants, and im-
ages of selected patients (II:1 and III:4) are shown in Fig. 2. 
Muscle atrophy was present in three (II:1, II:2, and II:3) of the 
seven patients. The following muscles were found to be atro-
phic: gastrocnemius medialis (6 muscles in 14 lower extremi-
ties examined), gastrocnemius lateralis (6/14), soleus (4/14), 
vastus lateralis (4/14), vastus medialis (1/14), vastus intermedi-
us (1/14), and rectus femoris (1/14) (Fig. 3). All atrophic mus-
cles were in the posterior compartment of the lower leg or the 
anterior compartment of the thigh. No atrophic muscles were 
present in the upper extremities, and no hypertrophy was 
found.
Fatty infiltrated muscles were found in four patients (II:1, 
II:2, II:3, and III:3), all of which were in the lower extremi-
ties, with the muscles in the posterior compartment of the 
lower leg more frequently and severely affected than those in 
other parts of the lower extremities (Fig. 4). In patient II:1, 
moderate fatty infiltration (score 3) was evident bilaterally in 
vastus lateralis, gastrocnemius medialis, and gastrocnemius 
lateralis, the left rectus femoris, the left vastus medialis, and the 
Forearm
Spine Adaptive
Forearm
Thigh Thigh
Lower leg Lower leg
A  B
Fig. 2. Whole-body MRI (T1-weighted images) of patients II:1 (A) and III:4 (B). A: Muscle atrophy with fatty infiltration is demonstrated in the an-
terior compartment of the thigh and the posterior compartment of the lower leg in patient II:1, the oldest (49-year-old) patient in this study. B: 
Conversely, in patient III:4, the youngest (14-year-old) patient in this study, all muscles appear normal. 
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left vastus intermedius, and mild fatty infiltration (score 2) was 
found in the right gluteus maximus, the right adductor mag-
nus, the right vastus intermedius, the left sartorius, and both 
solei. In patient II:2, moderate fatty infiltration was evident 
bilaterally in gastrocnemius medialis and gastrocnemius late-
ralis, and mild fatty infiltration was found bilaterally in vastus 
lateralis, the right semitendinosus, the right biceps femoris, 
the right adductor longus, the right adductor magnus, and 
both solei. In patient II:3, severe fatty infiltration (score 4) was 
evident bilaterally in gastrocnemius medialis and gastrocne-
mius lateralis. In patient III:3, mild fatty infiltration was evi-
dent in the left gastrocnemius medialis and gastrocnemius 
lateralis. 
Fat quantification
Fatty infiltration was quantified by assessing the fat fraction 
from fat and water maps derived from the in-phase and op-
posed-phase VIBE MR images (Fig. 5). The muscle fat frac-
tions as determined by the two-point Dixon technique are pre-
sented in Supplementary Table 2 (in the online-only Data 
Supplement).
Correlation between muscle fat fraction and  
patient age
The muscle fat fraction as measured by the two-point Dix-
on technique increased with patient age in the anterior thigh 
(r=0.669, p=0.009), in the deep posterior compartment of 
the lower leg (r=0.617, p=0.019), and in the superficial poste-
rior compartment of the lower leg (r=0.777, p=0.001) (Fig. 6). 
There were no significant correlations between patient age 
and fat fraction in muscles of the forearm (ventral and dorsal 
compartments), the medial and posterior thigh, and the ante-
rior and lateral compartments of the lower leg (Supplementa-
ry Table 3 in the online-only Data Supplement). 
Correlation between muscle fat fraction and  
manual muscle strength
There were no significant correlations between manual muscle 
strength and fat fraction of the muscle groups in the relevant 
regions (Supplementary Table 4 in the online-only Data Sup-
plement).
DISCUSSION
Fixed weakness and chronic progressive myopathy in pa-
tients with hyperKPP are difficult to assess, and there is a 
need for objective biomarkers to be identified. It is clinically 
impossible to distinguish fixed weakness from sustained epi-
sodic paralysis in hyperKPP patients. Although a muscle bi-
opsy may reveal muscle fiber atrophy with vacuoles,3 this 
No atrophy
Left
Right
Muscle atrophy
Fig. 3. Frequency of muscle atrophy observed in different muscle groups. All atrophic muscles are in the posterior compartment of the lower leg 
or the anterior compartment of thigh.
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procedure is invasive and inappropriate for the evaluation of 
muscle involvement patterns and disease progression. In this 
study we analyzed whole-body muscle MRI findings in pa-
tients with hyperKPP. Our results demonstrate that muscle at-
rophy and fatty infiltration-both of which are suggestive of 
chronic progressive myopathy-are present in hyperKPP pa-
Fig. 5. Muscle fat quantification of patient II:1 (A) and III:4 (B). A: Increased muscle fat fraction with muscle atrophy is demonstrated in the ante-
rior thigh and posterior compartment of the lower leg in patient II:1, the oldest (49-year-old) patient in this study. B: Conversely, in patient III:4, 
the youngest (14-year-old) patient in this study, the muscles of forearm, thigh, and lower leg do not show fatty infiltration or muscle atrophy.
A  B
Forearm
Thigh
Lower leg
T1WI T1WIIn-phase In-phaseWater map Water mapFat map Fat mapFat fraction Fat fraction
Fig. 4. Frequency and severity of fatty infiltration in different muscle groups. All fatty infiltrated muscles are in the lower extremities, with the 
muscles in the posterior compartment of lower leg more frequently and severely affected than those in other parts of the lower extremities.
Fatty infiltration
No fatty infiltration
Fatty streaks
30–60% fatty infiltration
>60% fatty infiltration
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tients, especially in older individuals. Muscle involvement 
showed a selective pattern, affecting the posterior compartment 
of the lower leg and anterior thigh muscles, and the muscle fat 
infiltration in these regions was found to increase with patient 
age.
Some patients with hyperKPP, especially older individuals, 
develop chronic progressive myopathy with fixed weakness.3 
In a recent survey of 94 genetically diagnosed hyperKPP pa-
tients, approximately 30% reported progressive myopathy 
with muscle dysfunction.4 Among several mutations in the 
SCN4A gene, the T704M mutation is most commonly associat-
ed with fixed weakness and chronic progressive myopathy in 
patients with hyperKPP.2 Similarly, muscle MRI performed in 
our study revealed atrophic muscles in three older patients 
(II:1, II:2, and II:3), although six of the seven patients had re-
ported weakness between attacks. Fatty infiltration was also 
more frequent and severe in older patients.
Whole-body muscle MRI is a useful technique for investi-
gating the patterns of the muscles involved in patients with 
myopathy.11 Identifying this pattern can aid the differential di-
agnosis and guide focused molecular analyses in many muscle 
disorders. For example, the preferential involvement of calf 
muscles is a distinct feature of Miyoshi myopathy, which is 
caused by mutations of the dysferlin gene.12,13 Although a pre-
vious MRI study demonstrated selective involvement of calf 
muscles in hyperKPP patients with fixed weakness,6 because 
that study only examined the lower legs, it could not reveal the 
muscle involvement patterns in other parts of the body. To 
the best of our knowledge, whole-body muscle MRI findings 
have not been described previously in patients with hyper-
KPP. Our study is therefore the first to demonstrate the highly 
selective involvement of muscles in the anterior thigh as well 
as the posterior compartment of the lower leg in hyperKPP 
patients. In addition, our use of the two-point Dixon method 
revealed that the fat fractions of muscles in the posterior com-
partment of the lower leg and the anterior thigh increased with 
patient age. Because this increase in fat fraction with age was 
not present in the other regions, the significant correlation be-
tween patient age and fat infiltration in the posterior compart-
ment of the lower leg and anterior thigh muscles strengthens 
our hypothesis of selective muscle involvement. This finding 
also supports the hypothesis that a portion of patients with hy-
perKPP develops a chronic progressive myopathy as they age. 
The muscle fat fraction was not correlated with manual 
muscle strength in this study. Chronic progressive myopathy 
associated with hyperKPP may cause mild muscle weakness. 
The manual muscle strength score in most patient muscles was 
8, 9, or 10. The presence of such mild muscle weakness between 
attacks in patients with hyperKPP means that manual muscle 
strength testing cannot be used to evaluate the disease severity 
and progression. In addition, it is difficult to clinically distin-
guish fixed weakness from sustained episodic paralysis in pa-
tients with hyperKPP, and the results of manual muscle testing 
are influenced by both patient effort and examiner variability. A 
previous muscle MRI study that quantified muscle fat in pa-
tients with Duchenne muscular dystrophy found that the mus-
cle fat fraction was strongly correlated with disease progression 
but not with the results of muscle strength tests, obtained either 
manually or with a dynamometer.14 Thus, muscle fat quantifi-
cation may provide a better assessment of disease progression 
and treatment response than clinical functional grading. How-
ever, further studies are needed to assess the viability of muscle 
fat quantification as an objective biomarker for disease progres-
sion and therapeutic response in hyperKPP.
This study was subject to several limitations and other is-
sues that should be considered when interpreting these re-
sults. First, the number of patients was small and all of them 
were from a single family. Further, the patient age was not 
distributed evenly, instead being dominated by those in early 
adulthood and in their late forties. These factors make it 
somewhat difficult to generalize the results to the wider pop-
ulation. Follow-up studies with larger samples and more-even 
age distributions will be necessary to further validate our find-
ings and confirm the pattern of selective muscle involvement 
that we observed in hyperKPP patients with a long disease 
duration. Second, this study did not include a control group. 
The main reasons for this were the high cost and long scan 
time of whole-body muscle MRI. However, despite the ab-
sence of a control group, the selective muscle involvement 
that we observed does not occur in healthy individuals, and 
so must be associated with the pathophysiology of hyperKPP. 
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Fig. 6. Two-point Dixon measurement of muscle fat fraction plotted 
against patient age. We observe that muscle fat fraction increases 
with age in the superficial posterior compartment of the lower leg 
(r=0.777; p=0.001).
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Future studies that compare whole-body muscle MRI find-
ings of patients with different mutations associated with hy-
perKPP may be necessary to investigate the genotype—phe-
notype correlation, especially with respect to chronic progressive 
myopathy. Lastly, in this study we used the two-point Dixon 
technique for fat quantification. Several variations of the orig-
inal two-point Dixon technique have been developed (e.g., three-
point, four-point, and multipoint methods) to reduce the sen-
sitivity to magnetic heterogeneities and phase errors associated 
with the two-point Dixon technique.15 However, these variant 
methods increase the scan time since they require the acquisi-
tion of additional images. Thus, scan-time limitations mean 
that these variant methods are not appropriate for whole-
body muscle MRI. Notably, a recent muscle fat MRI study us-
ing fat-water separation showed that the muscle fat fraction 
measured by the two-point Dixon technique is consistent with 
muscle histological measurements.16 Additionally, human mus-
cle fat quantification results obtained using the two-point Dixon 
technique were found to be more consistent with those from 
magnetic resonance spectroscopy than from the three-point 
or four-point Dixon technique.17
In conclusion, our whole-body muscle MRI findings pro-
vide evidence for fixed weakness and chronic progressive my-
opathy in patients with hyperKPP possessing the SCN4A mu-
tation T704M. We found that selective muscle involvement of 
the posterior compartment of the lower leg and the anterior 
thigh is characteristic of the chronic progressive myopathy, par-
ticularly in elderly patients, and these results may be useful for 
the differential diagnosis and targeted molecular analysis in 
hyperKPP. 
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